About the Authors
- Jinhua Xiang
-
Affiliation Iowa City VA Medical Center and the University of Iowa, Iowa City, Iowa, United States of America
- James H. McLinden
-
Affiliation Iowa City VA Medical Center and the University of Iowa, Iowa City, Iowa, United States of America
- Qing Chang
-
Affiliation Iowa City VA Medical Center and the University of Iowa, Iowa City, Iowa, United States of America
- Emma L. Jordan
-
Affiliation Iowa City VA Medical Center and the University of Iowa, Iowa City, Iowa, United States of America
- Jack T. Stapleton
-
* E-mail: jack-stapleton@uiowa.edu
Affiliation Iowa City VA Medical Center and the University of Iowa, Iowa City, Iowa, United States of America
Competing Interests
Drs. Xiang and Stapleton hold a patent (United States Patent No. 7,291,723) on the use of GBV-C as a therapeutic modality for HIV, and Drs. Xiang, McLinden and Stapleton have a patent application pending related to the use of NS5A as an anti-HIV therapy.
Author Contributions
Conceived and designed the experiments: JS JX JM. Performed the experiments: JX JM QC EJ. Analyzed the data: JS JX JM QC EJ. Contributed reagents/materials/analysis tools: JS JM. Wrote the paper: JS JX JM QC EJ.